While GWAS identified GluA1 dysfunction as a risk factor for schizophrenia [12], molecular and pharmacological studies over the past decade have linked GluA1 to depression, anxiety, stress-related behavior, and Alzheimer‘s disease [71,72,73,74]. Here, GRIA1 is linked to major depressive disorder.